Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study

by Yuzo Suzuki, Kazutaka Mori, Yuya Aono, Masato Kono, Hirotsugu Hasegawa, Koshi Yokomura, Hyogo Naoi, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Hidenori Nakamura, Takafumi Suda
Published 2021-07-01

Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratio

by S. N. Avdeev, N. V. Trushenko
Published 2018-10-01

Idiopathic Pulmonary Fibrosis in Elderly Patients: Analysis of the INSIGHTS-IPF Observational Study

by Gabriela Leuschner, Gabriela Leuschner, Gabriela Leuschner, Jens Klotsche, Michael Kreuter, Michael Kreuter, Antje Prasse, Antje Prasse, Antje Prasse, Hubert Wirtz, David Pittrow, Marion Frankenberger, Marion Frankenberger, Jürgen Behr, Jürgen Behr, Jürgen Behr, Nikolaus Kneidinger, Nikolaus Kneidinger, Nikolaus Kneidinger, The INSIGHTS-IPF Registry Group, Stefan Andreas, Thomas Bahmer, Martin Claussen, Sven Gläser, Christian Grohé, Lars Hagmeyer, Matthias Held, Nicolas Kahn, Joachim Kirschner, Dirk Koschel, Joachim F. Meyer, Claus Neurohr, Tim Oqueka, Martin Schwablmair, Dirk Skowasch, Tobias Welte, Henrike Wilkens
Published 2020-11-01

PREDICTION OF EFFICIENCY OF PYROGENAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C

by Chernyak S. A., Tsyrkunov V. M., Doroshenko Ye. M., Kapytski A. V.
Published 2018-08-01

Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity?

by Xin Huang, Yimin Khoong, Chengyao Han, Dai Su, Hao Ma, Shuchen Gu, Qingfeng Li, Tao Zan
Published 2021-07-01

A Review of Liver Fibrosis and Emerging Therapies

by Rooshi Nathwani, Benjamin H. Mullish, David Kockerling, Roberta Forlano, Pinelopi Manousou, Ameet Dhar
Published 2019-12-01

Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality

by Charlotte Hyldgaard, Janne Møller, Elisabeth Bendstrup
Published 2020-01-01

Interstitial lung diseases with progressive pulmonary fibrosis: pathogenetic features and approaches to therapy

by N. A. Kuzubova, O. N. Titova, D. B. Skliarova
Published 2020-11-01

Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype

by L. P. Ananieva, S. N. Avdeev, I. Е. Tyurin, A. М. Lila, A. I. Zagrebneva, А. L. Maslyanskiy, S. A. Terpigorev, I. V. Stepanyan, E. L. Lashina, O. V. Vasilieva, O. S. Lukina, E S. Pershina, А. А. Klimenko, N. A. Shostak, E. L. Nasonov
Published 2021-01-01

Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study

by V. Poletti, C. Vancheri, C. Albera, S. Harari, A. Pesci, R. R. Metella, B. Campolo, G. Crespi, S. Rizzoli, the FIBRONET study group
Published 2021-02-01

Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective

by Carlo Albera, Giulia Verri, Federico Sciarrone, Elena Sitia, Mauro Mangiapia, Paolo Solidoro
Published 2021-09-01

Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data

by Diaz Soto MP, Lim JK
Published 2020-08-01

Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies

by Wenshan Lv, Wenshan Lv, George W. Booz, Fan Fan, Yangang Wang, Richard J. Roman
Published 2018-02-01

Experimental and Investigational Targeted Therapies for the Management of Fibrosis in NASH: An Update

by Huisman TM, Dieterich DT, Friedman SL
Published 2021-03-01

Antifibrotic therapy to normalize the tumor microenvironment

by Anette Hauge, Einar K. Rofstad
Published 2020-05-01

Idiopathic pulmonary fibrosis patients with severe physiologic impairment: characteristics and outcomes

by Jean Pastre, Scott Barnett, Inga Ksovreli, Jeannie Taylor, A. Whitney Brown, Oksana A. Shlobin, Kareem Ahmad, Vikramjit Khangoora, Shambhu Aryal, Christopher S. King, Steven D. Nathan
Published 2021-01-01

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy

by Miriana d’Alessandro, Laura Bergantini, Paolo Cameli, Maria Pieroni, Rosa Metella Refini, Piersante Sestini, Elena Bargagli
Published 2021-02-01

Murine Precision-Cut Kidney Slices as an ex vivo Model to Evaluate the Role of Transforming Growth Factor-β1 Signaling in the Onset of Renal Fibrosis

by Elisabeth G. D. Stribos, Elisabeth G. D. Stribos, Marc A. Seelen, Harry van Goor, Peter Olinga, Henricus A. M. Mutsaers
Published 2017-12-01